Additionally, levels of NF-κB phosphorylation in PBMCs from patients with SLE could be decreased through IRAK1/4 inhibition or IRAK1 small interfering RNA (siRNA). This evidence concerns the gene NFKB1 and systemic lupus erythematosus.